成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>Transmembrane Transporters>Calcium Channel Inhibitors>Ranolazine
Ranolazine
  • Ranolazine

Ranolazine NEW

Price $57 $81 $125
Package 50mg 100mg 200mg
Min. Order:
Supply Ability: 10g
Update Time: 2024-11-19

Product Details

Product Name: Ranolazine CAS No.: 95635-55-5
Purity: 98.2% Supply Ability: 10g
Release date: 2024/11/19

Product Introduction

Bioactivity

NameRanolazine
DescriptionRanolazine (RS 43285-003) is a calcium uptake inhibitor via the sodium/calcium channel, used to treat chronic angina. It affects the sodium-dependent calcium channels during myocardial ischemia in rabbits by altering the intracellular sodium level.
Kinase AssayIn vitro kinase assay for CDK1 and Aurora kinases:CDK1 kinase activity is tested by the CDK1/cyclin B complex purified from baculovirus to phosphorylate a biotinylated peptide substrate containing the consensus phosphorylation site for histone H1, which is phosphorylated in vivo by CDK1. Inhibition of CDK1 activity is measured by observing a decreased amount of 33P-γ-ATP incorporation into the immobilized substrate in streptavidin-coated 96-well scintillating microplates. CDK1 enzyme is diluted in 50 mM Tris-HCl (pH 8), 10 mM MgCl2, 0.1 mM Na3VO4, 1 mM DTT, 1% DMSO, 0.25 μM peptide, 0.1 μCi per well 33P-γ-ATP, and 5 μM ATP in the presence or absence of various concentrations of JNJ-7706621 and incubated at 30 °C for 1 hour. The reaction is terminated by washing with PBS containing 100 mM EDTA and plates are counted in a scintillation counter. IC50 is determined by Linear regression analysis of the percent inhibition by JNJ-7706621.The Aurora kinase activity is measured with 10 μM ATP and a peptide containing a dual repeat of the kemptide phosphorylation motif.
In vitroIn the absence and presence of IK-blocking drugs, when late INa is increased, Ranolazine inhibits the late component of INa and attenuates prolongation of action potential duration. Ranolazine (10 mM) reduces by 89% of the 13.6-fold increase in variability of APD caused by 10 nM ATX-II. Ranolazine is found to bind more tightly to the inactivated state than the resting state of the sodium channel underlying I(NaL), with apparent dissociation constants K(dr)=7.47 mM and K(di)=1.71 mM, respectively. Ranolazine(5 mM and 10 mM) reversibly shortens the duration of TCs and abolishes the after contraction.
In vivoIn dog left ventricular myocytes, Ranolazine significantly and reversibly stimulate the action potential duration (APD) of shortened myocytes at 0.5 or 0.25 Hz in a concentration-dependent manner. In rat hearts, Ranolazine (10 mM) significantly increased 1.5-fold to 3-fold under glucose oxidation conditions. Ranolazine (10 mM) also increased glucose oxidation (high calcium, low FA; 15 ml/min) in Langendorff hearts in normoxic rats. Ranolazine significantly improves the function of the reperfused ischemic working heart, which is associated with a significant increase in glucose oxidation function.
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility InformationH2O : < 1 mg/mL (insoluble or slightly soluble)
Ethanol : 16 mg/mL (37.4 mM)
DMSO : 60 mg/mL (140.34 mM)
KeywordsCVT303 | Na+ channels | Ca2+ channels | inhibit | CVT-303 | Sodium Channel | Inhibitor | Calcium Channel | Ranolazine | Na channels | Ca channels
Inhibitors RelatedNisoldipine | Phenytoin sodium | Diltiazem hydrochloride | L-Ascorbic acid | Lidocaine | Lanthanum(III) chloride heptahydrate | Lidocaine hydrochloride | L-Aspartic aicd sodium | Ethyl cinnamate | 1-Octanol
Related Compound LibrariesBioactive Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Inhibitor Library | Neuroprotective Compound Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Bioactive Compounds Library Max | Ion Channel Targeted Library | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/1g
VIP1Y
Cangzhou Kangrui Pharma Tech Co. Ltd.,
2024-10-17
$0.00/25kg
VIP1Y
PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD
2024-05-21
$10.00/1Kg/Bag
Hebei Zhanyao Biotechnology Co. Ltd
2021-11-19
$15.00/1KG
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-10
$0.00/1Kg/Bag
VIP4Y
WUHAN FORTUNA CHEMICAL CO., LTD
2021-07-03
$300.00/1KG
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
2020-12-22
$0.00/1KG
WUHAN CIRCLE POWDER TECHNOLOGY CO.,LTD
2020-10-24
$60.00/1KG
Hebei shuoxi biotechnology co. LTD
2019-11-05
$0.00/25KG
Jinan Shengqi pharmaceutical Co,Ltd
2019-03-02
$2.00/1kg
VIP7Y
Career Henan Chemical Co
2018-12-23
  • Since: 2011-01-07
  • Address: 36?Washington?Street, Wellesley?Hills
INQUIRY